Evidence map›Paper›PMID 20421471›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Fast on-rates allow short dwell time ligands to activate T cells.

Christopher C Govern, Michelle K Paczosa, Arup K Chakraborty, Eric S Huseby

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Differential roles of kinetic on- and off-rates in T-cell receptor signal integration revealed with a modified Fab'-DNA ligand.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. T-cell virtuosity in ''knowing thyself".Frontiers in immunology · 2024
    Review
  11. Mathematical models of TCR initial triggering.Frontiers in immunology · 2024
    Review
  12. Article
  13. Article
  14. CD4Nature immunology · 2023
    Review
  15. Article
  16. I-ANature immunology · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christopher C GovernDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Michelle K Paczosa
Arup K Chakraborty
Eric S Huseby

Funding

Interdepartmental Biotechnology Training ProgramT32GM008334 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WITTRUP, KARL DANE · 1989 to 2018
$15.2M
PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
Visualizing, Quantifying, and Modeling of T Cell Response to Listeria InfectionP01AI071195 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI DUSTIN, MICHAEL LORAN · 2006 to 2010
$8.1M
NIAID NIH HHS 1P01AI07/1195/01NIAID NIH HHS P01 AI071195NIDDK NIH HHS DK32520NIDDK NIH HHS P30 DK032520NIGMS NIH HHS T32 GM008334
6 · The paper itself

Abstract

Two contrasting theories have emerged that attempt to describe T-cell ligand potency, one based on the t(1/2) of the interaction and the other based on the equilibrium affinity (K(D)). Here, we have identified and studied an extensive set of T-cell receptor (TCR)-peptide-MHC (pMHC) interactions for CD4(+) cells that have differential K(D)s and kinetics of binding. Our data indicate that ligands with a short t(1/2) can be highly stimulatory if they have fast on-rates. Simple models suggest these fast kinetic ligands are stimulatory because the pMHCs bind and rebind the same TCR several times. Rebinding occurs when the TCR-pMHC on-rate outcompetes TCR-pMHC diffusion within the cell membrane, creating an aggregate t(1/2) (t(a)) that can be significantly longer than a single TCR-pMHC encounter. Accounting for t(a), ligand potency is K(D)-based when ligands have fast on-rates (k(on)) and t(1/2)-dependent when they have slow k(on). Thus, TCR-pMHC k(on) allow high-affinity short t(1/2) ligands to follow a kinetic proofreading model.

Indexed as

AnimalsCD4-Positive T-LymphocytesCell ProliferationHalf-LifeHistocompatibility AntigensKineticsLigandsLymphocyte ActivationMiceMice, Inbred C57BLModels, ImmunologicalPeptidesProtein BindingReceptors, Antigen, T-CellSolubilityTime FactorsHistocompatibility AntigensLigandsPeptidesReceptors, Antigen, T-Cell

Identifiers

PMID20421471
PMCPMC2889346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.